Company intelligence / Profile preview

Chengdu Yun Yi Dian Biological Technology

Chengdu, Sichuan Sheng, Chinacbmexpochina.com ↗

Ownership: Private
Development stage: Other

Overview

Chengdu Yun Yi Dian Biological Technology is an active Chinese biotech company founded in 2018 and based in Sichuan province. It operates primarily as a contract research and manufacturing organization providing R&D and production services for chemical and pharmaceutical enterprises. The company is a subsidiary of Shanghai Anmaibo Biomedical, which has its own independent R&D center and production base. In 2021, it was recognized as a "young eagle enterprise" for innovation within Wenjiang District, Chengdu. No specific clinical results or proprietary drug pipeline are publicly disclosed.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on Chengdu Yun Yi Dian Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chengdu Yun Yi Dian Biological Technology.

Explore the full profile